Nicaragua approves Russia's Sputnik Light single-dose vaccine - wealth fund

Reuters, 20.05.2021

MOSCOW, May 20 (Reuters) - Nicaragua on Thursday approved Russia’s single-dose Sputnik Light vaccine against coronavirus, the Russian Direct Investment Fund (RDIF), responsible for marketing Russian vaccines abroad, said, citing Nicaragua’s health ministry.

Developed by Moscow’s Gamaleya Institute, the slimmed-down vaccine, which the RDIF said is 79.4% effective against COVID-19 and costs under $10 a dose, has been earmarked for export and has been billed as a way to help vaccine supplies go further in countries with high infection rates.